Evidence map›Paper›PMID 29961673›Full record

Observational studyBioscience reports2018

Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection.

Tatiana V Kirichenko, Veronika A Myasoedova, Tatiana E Shimonova, Alexandra A Melnichenko, Dmitri Sviridov, Igor A Sobenin, Alexey I Mazus, Alexander N Orekhov, Michael I Bukrinsky

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Tatiana V KirichenkoInstitute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.
Veronika A MyasoedovaUnit for Clinical Research in Atherothrombosis, Centro Cardiologico Monzino, Milan, Italy.
Tatiana E ShimonovaMoscow City Center for AIDS Prevention and Control, Moscow City Health Department, Moscow, Russia.
Alexandra A MelnichenkoSouthern Federal University, Department of Genetics, Rostov-on-Don, Russia.
Dmitri SviridovBaker Heart and Diabetes Institute, Laboratory of Lipoproteins and Atherosclerosis, Melbourne, Australia.
Igor A SobeninInstitute of General Pathology and Pathophysiology, Laboratory of Angiopathology, Moscow, Russia.
Alexey I MazusMoscow City Center for AIDS Prevention and Control, Moscow City Health Department, Moscow, Russia.
Alexander N OrekhovInstitute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.
Michael I BukrinskyThe George Washington University School of Medicine and Health Sciences, Department of Microbiology, Immunology and Tropical Medicine, Washington, DC, U.S.A. mbukrins@gwu.edu.
Regional Center for Prevention and Control of AIDS and Infectious Diseases · RUBaker Heart and Diabetes Institute · AUCentro Cardiologico Monzino · ITInstitute for Atherosclerosis Research · RUInstitute of Experimental Cardiology · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUSouthern Federal University · RU

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
HIV Disease and Impairement of High Density Lipoprotein MetabolismR01HL101274 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, FITZGERALD, MICHAEL LEO · 2010 to 2015
$4.0M
Metabolic complications of HIV disease caused by Nef released from HIV-infected cellsR01HL131473 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, SVIRIDOV, DMITRI · 2016 to 2019
$1.6M
NHLBI NIH HHS R01 HL101274NHLBI NIH HHS R01 HL131473NIAID NIH HHS P30 AI051519NIAID NIH HHS P30 AI117970
6 · The paper itself

Abstract

HIV infection is associated with the increased risk of cardiovascular disease (CVD), even in patients successfully treated with the combination antiretroviral therapy (cART). However, the relationship between HIV, cART, and pathogenesis of CVD remains controversial. In the present study, we evaluated the carotid intima-media thickness (CIMT), a surrogate marker of atherosclerosis, in HIV-infected subjects receiving or not receiving cART. One hundred nine newly diagnosed HIV-infected subjects and one hundred nine uninfected age-matched controls (all males) without the history of CVD, hypertension, or diabetes were recruited into the present study. Cross-sectional analysis at baseline (BL) showed significantly increased levels of triglycerides (TG) and decreased levels of high-density lipoprotein (HDL) in HIV-infected subjects, indicating that these risk factors for CVD appeared during the undiagnosed period of HIV infection. Nevertheless, no differences in CIMT were detected between the groups, suggesting that these risk factors were yet to be translated into the clinical disease. The prospective arm of the study, which included 37 HIV-infected and 23 uninfected subjects, showed higher CIMT increase in HIV-infected group than in control group (

Indexed as

AdultAnti-Retroviral AgentsAtherosclerosisCarotid Intima-Media ThicknessCross-Sectional StudiesHIV InfectionsHumansLipoproteins, HDLMaleMiddle AgedProspective StudiesTriglyceridesAnti-Retroviral AgentsLipoproteins, HDLTriglyceridesanti-retroviral treatmentatherosclerosiscarotid intima media thicknesscross sectional studyHIVprospective study

Identifiers

PMID29961673
PMCPMC6050190
OpenAlexW2810866416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.